Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc.

The latest update is out from National Bank Holdings ( ($NBHC) ). On November 3, 2025, National Bank Holdings Corporation (NBHC) released an update...

National Bank Holdings Updates Investor Presentation

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Butterfly Network (BFLY – Research Report), Bausch...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (BFLY), Bausch Health Companies (BHC) and Tenet Healthcare (THC)

An update from National Bank Holdings ( ($NBHC) ) is now available. On October 29, 2025, National Bank Holdings Corporation announced a 3.3% increa...

National Bank Holdings Increases Quarterly Dividend by 3.3%

Brand House Collective ( ($TBHC) ) just unveiled an update. On October 20, 2025, Brand House Collective, Inc. announced the appointment of Lisa Fol...

Current Quarter	$1.23	Next Quarter	$0.84
Current Year	$3.85	Next Year	$4.11
QoQ Growth	-31.7%	YoY Growth	+6.8%
3Y EPS CAGR	+63.3%	Target Price	$7.17
Consensus	Buy	Upside	+18.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BHC	$6.03	+0.50%	1.31M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BHC	$6.03	+0.5%	1.31M
3
4
5
6

BHC

BHC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Bausch Health Companies Inc. Data in Excel

Get Bausch Health Companies Inc. Data in Excel